IAM Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
IAM Advisory's LLY Position: Q2 2026 in Review
IAM Advisory reduced its Eli Lilly (LLY) stake by 0.28% in Q2 2026, selling an estimated $13.3K and leaving 4,638 shares worth $5.56M. The position accounts for 1.08% of the portfolio, ranked #18.
IAM Advisory first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- IAM Advisory held 4,638 shares of Eli Lilly worth $5.56M as of Q2 2026.
- IAM Advisory sold 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
- Eli Lilly made up 1.08% of IAM Advisory's portfolio in Q2 2026, its #18 holding.
- IAM Advisory first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on IAM Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.